Saturday, August 1, 2026

Samsung Bioepis Secures U.S. Approval for Pen-Style Stelara Biosimilar, Setting a Market First

Samsung Bioepis receives FDA approval for Epyztek, the first pre-filled pen for autoimmune treatments, enhancing patient convenience.

Why U.S. Police Are Switching to Samsung’s Galaxy Z Flip for Body Cams

Samsung Electronics announced that the adoption of the Galaxy Z Flip as a body camera by U.S. police is increasing.

North Korea-China Economic Cooperation Accelerates After September Visit As Regime Nears Diplomatic Normalization Amid Strategic Dual-Usage By Powers

Kim Jong Un's China visit boosts economic ties, with experts noting China's strategy to leverage North Korea amid U.S. tensions.

Health

Enhanced Recovery Protocol Speeds Recovery After Brain Aneurysm Surgery, Study Finds

Enhanced Recovery After Surgery (ERAS) can significantly improve recovery speed for patients undergoing brain aneurysm surgery.

Celltrion’s Omlyclo Gains Traction in Italy, Reinforcing Direct Sales Strategy as Growth Expected to Accelerate

Celltrion expands its biosimilar supply in Italy, enhancing its competitiveness in the European pharmaceutical market.

CG Bio Treats First U.S. Patient With Bone Graft Substitute, Advances FDA Approval

Sigibio accelerates clinical development for FDA approval after the first U.S. patient procedure with its next-gen bone substitute, Novosis Putty.

Is Winuf IV the Future of Nutritional IV Therapy? A Deep Dive into Omega-3’s Role in Healing

JW Pharmaceutical introduces clinical applications of omega-3 based nutrient infusion Winuf Inj. to medical professionals.

Next-Gen Surface Induction Radiation Therapy: A Game Changer for Breast Cancer Patients?

Breast cancer patients may soon avoid discomfort from tattoos or markings during radiation therapy.
Latest

NVP Healthcare Signs Exclusive Supply Deal for NVP-1702 With Brazil’s Marjan Farma at BIO USA

NVP Healthcare signs a deal with Marjan Farma to supply its probiotic NVP-1702 for liver health products in Brazil, aiming for market expansion.

Shaperon to Expand Biobeauty Business With NeedsTech, Targeting Hong Kong, Taiwan and U.S. Markets

Shaperon is acquiring NeedsTech to enhance its biobeauty business and expand globally, targeting markets in Hong Kong, Taiwan, and the U.S.

From Keycaps to World Cup Matches, K-Bio Turns BIO USA Into a Marketing Showcase

The BIO International Convention 2026 showcased innovative marketing and cultural engagement, enhancing the biotech industry's global appeal.

Is BTGEN the Next Big Player in Biopharmaceuticals? Discover Their Unique CDMO Strategy

BTGEN is expanding its CDMO business with National Growth Fund support, focusing on innovative processes instead of competing on scale.

K-Bio’s Global Leap: How Korea’s Biotech is Shaping Asia’s Innovation Hub

The BIO USA 2026 highlighted Korea's biotech growth, emphasizing the need for increased capital to enhance global competitiveness.

K-Beauty Shines at BIO USA 2026: Discover the Future of Bio-Integrated Skincare!

K-Beauty showcased its biotech innovations at BIO USA 2026 with a pop-up store, attracting global attention and business opportunities.

Samsung Biologics Expands Global Reach: New European Sales Office Set to Boost Biopharmaceuticals Market

Samsung Biologics expands its global sales network with a new office in Europe, aiming for growth in production and portfolio diversification.

Gilead Launches CAR-T Therapy Yescarta in Korea, Offering Fourfold Survival Benefit for Relapsed or Refractory Lymphoma Patients

Yescarta is widely used for second-line treatment in patients with very low survival rates, and should be adopted as a standard treatment in Korea.

ST Pharm Targets Next-Generation RNA Therapies, Positions Itself as Key CDMO Partner at BIO USA

The RNA therapeutics market is evolving, with ST Pharm aiming to lead in precision manufacturing and targeted delivery for next-gen therapies.

“Cheers” in San Diego: K-Biopharma Showcases Growing Global Influence at BIO USA Networking Event

KPBMA supports Korean pharma's global expansion at BIO USA, boosting international interest and partnerships in the biotech sector.

Korean Biopharma Takes Center Stage at BIO USA as Industry Giants and Biotechs Expand Global Reach

The BIO USA 2026 convention gathers over 20,000 bio industry professionals, highlighting the growing presence of Korean companies.

How AI is Revolutionizing Drug Development: Insights from BIO International Convention 2026

The 2026 BIO International Convention focuses on AI, shifting from technology introduction to validating business outcomes.

Dong-A ST Eyes Early-Stage Licensing Deals as Key Growth Strategy, Says VP Oh Yoon-seok [BIO USA]

Dong-A ST aims for global expansion by licensing preclinical drug candidates, focusing on timely execution of R&D strategies by 2027.

Alteogen CEO Says Additional Licensing Deals Near Completion, Highlights Patent Strength [BIO USA]

Alteogen is nearing global licensing deals, focusing on maximizing value and expanding its platform technology in biopharma.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.